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Background: Aggregatibacter-actinomycetemcomitans (A.actinomycetemcomitans) are strongly associated with 
localized-aggressive-periodontitis (LAgP). The study’s aim was to test for the first time the effect of total soni-
cated A.actinomycetemcomitans-bacterial-fragments on gingival mesenchymal stem/progenitor cells’ (G-MSCs) 
proliferation and regenerative gene expression in-vitro. 
Material and Methods: G-MSCs were isolated, characterized, expanded and stimulated by total sonicated 
A.actinomycetemcomitans-bacterial-fragments (0 (negative-control), 15, 60, 120 and 240µg/ml; serovar-b; n=6/
group). Cellular proliferation and NF-κβ (NFKB1), Alkaline Phosphatase (ALPL), Collagen-I (COL1A1), Colla-
gen-III (COL3A1), Osteonectin (SPARC) and Osteopontin (SPP1) m-RNA expression were assessed via reverse-
transcription-polymerase-chain-reaction (RT-PCR) at 24, 48 and 72 hours and CFUs-ability evaluated at twelve 
days.
Results: G-MSCs demonstrated stem/progenitor cells’ characteristics. A.actinomycetemcomitans-bacterial-
fragments (up to 72 hours) resulted in marked G-MSCs’ proliferation over-time (p<0.001) and elevated NFKB1 
(p=0.017), COL1A1 (p=0.025), SPARC (p=0.025), decreased ALPL (p=0.017), with no significant differences for 
COL3A1 and SPP1 expression or stimulation times (p>0.05; Friedman-test). Longer-term stimulation for twelve 
days reduced G-MSCs’ CFUs. 
Conclusions: Sonicated A.actinomycetemcomitans-bacterial-fragments’ exert beneficial short-term effects on G-
MSCs’ proliferative and non-mineralized tissue forming aptitude. Results shed new light on the importance of peri-
odontal treatment for LAgP patients, using power driven sonic/ultrasonic devices, which, in addition to reducing the 
subgingival microbial load, produces cell-stimulatory A.actinomycetemcomitans-bacterial-fragments, with positive 
attributes on tissue reparative/regenerative responses of tissue resident stem/progenitor cells in their niche. 
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Introduction
Periodontitis, a bacterially induced inflammatory disor-
der, is branded by the destruction of the tooth-bearing 
and investing tissues; including the periodontal liga-
ment, the alveolar bone, the cementum and the gingiva 
(1). Two variants of periodontal diseases categorized 
under Aggressive Periodontitis (AgP) (2), a localized 
(LAgP) and a generalized (GAgP) form, affecting 0.1%-
7.6% of young healthy individuals (3), are branded by a 
high rate of disease progression and a tendency towards 
familial aggregation (4). The disease process is believed 
to be initiated by a microbial challenge, with a subse-
quent aggressive inflammatory response and periodon-
tal tissue destruction (5). These aggressive forms most-
ly correlate with the presence of specific highly virulent 
bacterial species in the subgingival biofilm with a pre-
dominance of Gram-negative anaerobic rods (6). Al-
though data concerning this linkage are mainly based on 
association studies, the Gram-negative Aggregatibacter 
actinomycetemcomitans (A.actinomycetemcomitans) 
species, implicated in chronic periodontitis and severe 
non-oral infections (seven serovars a-g) (7), is assumed, 
especially serovar-b, to be one of the primary etiologi-
cal agents of LAgP (8,9). A.actinomycetemcomitans 
is capable of active tissue invasion (10,11), using cells 
as a reservoir for initial attachment, before eventually 
moving to non-shedding tooth surfaces, and produces 
a unique array of virulence factors, including the cyto-
lethal distending toxin (Cdt) and the leukotoxin (LtxA) 
(12).
Reducing the A.actinomycetemcomitans microbial load, 
through mechanical removal of supra- and subgingival 
deposits (13) via periodontal scaling and root planning 
(SRP), is standardly employed during LAgP treatment 
and maintenance phases, to produce a biologically com-
patible subgingival environment for reattachment/new 
attachment of adjacent periodontal tissues (14). Power-
driven sonic/ultrasonic instruments allow hereby an 
easy, fast, gentle yet thorough root surface debridement, 
with high efficacy and advantageous ergonomics (15-
18), during surgical and non-surgical periodontal ther-
apy. The instruments perform their action though the 
physical effect of their oscillating tips, increasing the 
convection in the otherwise stagnant or relatively slow 
moving subgingival fluid via acoustic micro-streaming. 
High-energy shock waves are alluded to be produced 
through cavitating gas bubbles in the liquid, which dis-
lodge root adherent deposits, and disrupt and lyse the 
surrounding bacteria through the produced shear stress-
es (19). The produced mixture of fragmented bacterial 
constituents, could access the gingival connective tis-
sue through periodontal pocket-lining inflammatory-in-
duced micro-ulcerations and the surgical/non-surgical 
therapy, interacting with resident gingival mesenchy-
mal stem/progenitor cells (G-MSCs) in their niche, pos-
sibly affecting their cellular and regenerative attributes, 
during the subsequent periodontal wound healing/re-
generative phases.
The present study’s aim was to test for the first time the 
effect of the total sonicated A.actinomycetemcomitans-
bacterial-fragments on G-MSCs’ proliferation and re-
generative gene expression in vitro. 
Material and Methods
-Isolation and culture of G-MSCs
G-MSCs isolation was done as earlier described (20,21). 
Concisely, after attaining the patients’ informed consent 
(IRB:D444/10), free gingival collars attached to extract-
ed third molars were surgically excised at the Christian-
Albrechts-University-Kiel, Germany. The gingival tissue 
collars were de-epithelised, cut into pieces, rinsed with 
alpha-modification-Minimum Essential Medium Eagle 
(α-MEM; Sigma-Aldrich GmbH, Hamburg, Germany) 
augmented with antibiotics (100 µg/ml streptomycin, 
100 U/ml penicillin) and 1% amphotericine (all from Bio-
chrom AG, Berlin, Germany) and placed in dry culture 
flasks (Sarstedt AG, Nümbrecht, Germany) for 30 minutes 
to adhere to their bottoms. Subsequently, basic medium 
consisting of α-MEM, augmented with 15% Fetal Calf 
Serum (FCS; HyClone, Logan, UT, USA), 400 mmol/ml 
L-glutamine (Biochrom), 100 U/ml penicillin, 100 µg/ml 
streptomycin and 1% amphotericine was carefully added. 
Flasks were incubated in 5% CO2 at 37°C and cells left to 
grow out and the basic medium changed three times/week. 
After reaching 80-85% confluence, cells were detached 
with 0.10% trypsin-EDTA (Biochrom) and counted. Their 
viability was tested using Trypan Blue (Sigma-Aldrich) to 
be finally seeded as 30 cells/cm² (22) in basic medium in 
5% CO2 at 37°C. After the first passage cells reached 80-
85% confluence, they were subjected to immunomagnetic 
cell sorting, using anti-STRO-1 (BioLegend, San Diego, 
CA, USA) and anti-IgM MicroBeads (Miltenyi Biotec, 
Bergisch Gladbach, Germany) antibodies, according to 
manufacturers’ instructions (MACS; Miltenyi Biotec). 
Positively sorted cell fractions (G-MSCs) were seeded out 
to form colony-forming units (CFUs).
-Colony-forming units (CFUs) 
To assess colony-forming efficiency, G-MSCs were cul-
tured in basic medium at a density of 1.63 cells/cm2. 
Aggregates of 50 or more cells were scored as colonies. 
On the twelfth day, a demonstrative sample of the cul-
tures was fixed with 4% formalin, stained with 0.1% 
crystal violet. From the remainder of the CFUs forming 
G-MSCs single colonies were detached by cell scrapers 
(23,24) and seeded out in basic medium.
-Multilineage differentiation potential
To test for osteogenic differentiation, 2×104 second pas-
sage G-MSCs were cultured on 6-well culture plates 
in osteogenic inductive medium (PromoCell, Heidel-
berg, Germany). As controls, G-MSCs were cultured 
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in basic medium. At day 14, cultures were stained with 
Alizarin-Red (Sigma-Aldrich), to mark calcified depos-
its. To test the adipogenic differentiation, 3×105 second 
passage G-MSCs were cultured on 6-well culture plates 
in adipogenic inductive medium (PromoCell). As a 
control, G-MSCs were cultured in basic medium. The 
presence of lipid droplets was evaluated by Oil-Red-O 
staining (Sigma-Aldrich). To test for chondrogenic dif-
ferentiation, micro-masses of 3×104 second passage G-
MSCs were incubated with chondrogenic inductive me-
dium (PromoCell) in 6-well culture plates (Sarstedt AG, 
Germany). As a control, G-MSCs were cultured in basic 
medium. Chondrogenic differentiation was evaluated at 
day 35 by staining of glycosaminoglycans with Alcian-
Blue and nuclear-fast-red counter staining (Sigma-Al-
drich) (25). All media were renewed three times/week.
-Bacterial strains, growth conditions and fragmentation
A.actinomycetemcomitans serovar-b, strain Y4, DSMZ 
11123 (DMSZ, Braunschweig, Germany), originally 
isolated from subgingival dental plaque, were grown 
in BD-Bacto™ Brain-Heart-Infusion (BHI; 237500, 
BD, Heidelberg, Germany) under microaerobic condi-
tions for 48 hours at 37C°. From this starter culture 10 
ml was taken in 1000 ml fresh BHI and cultured over-
night. A sample of the late exponential-phase cultures 
(OD600=0.5) were Gram-stained and the rest har-
vested by centrifugation at 1200 g, washed twice and 
resuspended in PBS. Bacteria were disrupted by 20 
kHz sonication in an ice bath using 30 seconds puls-
es separated by 30 seconds breaks (Labsonic 2000U; 
B.Braun Biotech, Melsungen, Germany). The prepara-
tions were centrifuged at 12000 g for 10 minutes (JA-
18, Beckman Coulter, Krefeld, Germany) to remove 
unfragmented cells and sterile-filtrated by passage 
through a 0.2 µm pore size filter (Merck Millipore, 
Darmstadt, Germany). Bacterial CFUs-test of the fil-
trate was negative, confirming the absence of living 
bacteria. Total sonicated A.actinomycetemcomitans-
bacterial-fragments were determined with the Micro 
BCA Protein Assay kit (Thermo-Fisher Scientific, 
Schwerte, Germany). The toxic dose (TD50) concen-
tration was determined at 72 hours incubation of the 
sonicated A.actinomycetemcomitans-bacterial-frag-
ments with G-MSCs, as previously described (26). 
-G-MSCs stimulation
TD50 was obtained at a concentration of 240 µg/ml to-
tal sonicated A.actinomycetemcomitans-bacterial-frag-
ments. Accordingly, a downward logarithmic concen-
tration scale was prepared. 2×104 third passage G-MSCs 
were cultured in 6-well culture plates. After initial cell-
adhesion, five experimental groups received total soni-
cated A.actinomycetemcomitans-bacterial-fragments in 
basic medium at concentrations (0 (negative-control), 
15, 60, 120 and 240 µg/ml, n=6/group) for 24, 48 and 
72 hours each.
-Cell proliferation assays
Cell proliferation and viability was determined in 
the five groups at 24, 48 and 72 hours using the MTT 
(3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium-
bromide) Cell Proliferation Kit-I (Roche, Mannheim, 
Germany). Third passage G-MSCs were seeded in 96-
well cell culture plates at a density of 1×103 cell/well. 
After adhesion (day 0), cells were cultured and stimu-
lated according to the group allocation described above. 
At 24, 48 and 72 hours, the media were replaced by no 
phenol-red serum-free medium (RPMI 1640, PAN-
Biotech, Aidenbach, Germany). 10 μl MTT labelling 
reagent (final concentration 0.5 mg/ml) was added into 
each well and incubated for 4 hours (37°C, 5% CO2). 1 
ml of the Solubilization solution was added into each 
well and incubated overnight (37°C, 5% CO2). The 
spectrophotometrical absorbance was measured using 
a universal microplate spectrophotometer (μQuant, 
BioTek Instruments, Vermont, USA) at 570 nm wave-
length. Relevant cell numbers were calculated accord-
ing to standard curves. Each assay was performed in 
triplicate and averaged. 
-CFUs-assay
To assess colony-forming efficiency, third passage G-
MSCs were seeded out at a density of 1.63cells/cm2. Fol-
lowing their adherence, cells were stimulated according 
to the group allocation described above and media re-
newed three times/week. On the twelfth day, demon-
strative cultures were fixed with 4% formalin, stained 
with 0.1% crystal violet. Aggregates of 50 or more cells 
were scored as colonies, counted independently by two 
examiners and averaged.
-m-RNA extraction and cDNA synthesis
m-RNA extraction was performed for third passage G-
MSCs of the five groups at 24, 48 and 72 hours, using 
the RNeasy kit (Qiagen, Hilden, Germany), accord-
ing to the manufacturer’s instructions. The obtained 
RNA was purified using RNase-free-DNase (Promega, 
Mannheim, Germany), and quantified photometri-
cally. To perform two-step RT-qPCR, complementary 
cDNA was synthesized from 1-13 μl of RNA (1 μg/μl) 
by reverse transcription (RT) kit (QuantiTect; Qiagen), 
according to the manufacturer’s instructions (Master-
cyclergradient; Eppendorf). In a volume of 20 μl reac-
tion mixture containing 4 pmol of each primer, 10 μl 
of the LightCycler Probes Master mixture (Roche) and 
5 μl specimen cDNA the second PCR step was then 
performed. The expression of the inflammatory gene 
NF-κβ (NFKB1) and the regenerative transcription 
factors alkaline phosphatase (ALPL), type-I collagen 
(COL1A1), type-III collagen (COL3A1), osteonectin 
(SPARC) and osteopontin (SPP1) were measured using 
reverse transcription-polymerase chain reaction (RT-
PCR, LightCycle, Roche Molecular Biochemicals, Indi-
anapolis, IN, USA). The housekeeping gene PGK1 was 
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Fig. 1. Isolation and characterization of G-MSCs. (A) Microscopic appearance of outgrowing cells from free gingival margin 
connective tissue. (B) Microscopic appearance of CFUs of G-MSCs stained with crystal violet. (C) Gram-staining of Aggrega-
tibacter actinomycetemcomitans (A.actinomycetemcomitans) colonies. (D) Alizarin Red staining of G-MSCs after osteogenic 
induction. (E) Oil Red O staining of G-MSCs after adipogenic stimulation. (F) Alcian Blue and nuclear-fast-red counter stain-
ing of G-MSCS after chondrogenic stimulation. (G) Alizarin Red staining of G-MSCs cultured in basic medium. (H) Oil Red 
O staining of G-MSCs cultured in basic medium. (I) Alcian Blue and nuclear-fast-red counter staining of G-MSCs cultured in 
basic medium.
used as a reference. The Real Time Ready Assays were 
supplied by Roche Diagnostics (Table 1). The relative 
quantification of the gene expression was performed by 
the 2^-ΔΔCt method. All experiments were performed 
in triplicate and averaged.








Table 1: Primer names and ID used for real-time PCR (as supplied 
by Roche).
-Statistical analysis
Shapiro-Wilk-Test was used to test for normality of 
the data. Differences in cell proliferation, expression 
of the inflammatory gene NFKB1 and the regenera-
tive transcription factors ALPL, COL1A1, COL3A1, 
SPARC and SPP1 were tested between the different 
experimental groups and stimulation times, using the 
two-way nonparametric Friedman-test. A Wilcoxon-
signed-rank-test was performed for post-hoc multiple 
comparisons, using the SPSS software (SPSS version 
20, SPSS, Chicago, IL). The level of significance was 
set at p=0.05.
Results
-Phase contrast inverted microscopy, CFUs and bacte-
rial staining
Following the initial adherence phase, cells grew out of 
the gingival soft tissue masses, forming adherent fibro-
blast-like clusters (Fig. 1A). Twelve days after seeding, 
G-MSCs showed CFUs (Fig. 1B). Late phase exponen-
















































































































































































































































































































tial phase of A.actinomycetemcomitans-bacterial colo-
nies stained Gram-negative (Fig. 1C).
-Multilineage differentiation potential
Osteogenic differentiation of G-MSCs was demonstrat-
ed by the formation of calcified deposits labelled with 
Alizarin-Red, in contrast to their controls (Fig. 1D,G). 
Adipogenic differentiation of G-MSCs resulted in the 
formation of lipid droplets positively stained with Oil-
Red-O, in contrast to their controls (Fig. 1E&H). Chon-
drogenic differentiation of G-MSCs resulted in the for-
mation of glycosaminoglycans positively stained with 
Alcian-Blue and nuclear-fast-red counter staining, in 
contrast to their controls (Fig. 1F,I). 
-G-MSCs’ proliferation and CFUs-assay
Total sonicated A.actinomycetemcomitans-bacterial-
fragments stimulated groups showed generally lower 
G-MSCs’ proliferation compared to the negative-con-
trol group, following a 24 hours stimulation phase. 
At 48 and 72 hours, this pattern was reversed, with 
A.actinomycetemcomitans-bacterial-fragments stimu-
lated G-MSCs showing higher proliferative activ-
ity. MTT results demonstrated significant increase 
in cell numbers over the 72 hours (p<0.001, Fried-
man-test). With G-MSCs numbers remaining almost 
constant in the control group at 24, 48 and 72 hours, 
A.actinomycetemcomitans-bacterial-fragments signifi-
cantly activated cell proliferation between each of the 
time-points (p<0.001 Wilcoxon-signed-rank-test). The 
overall highest cell numbers were demonstrated with 
15 µg/ml A.actinomycetemcomitans-bacterial-frag-
ments stimulation at 72 hours [Median:9226.5 (Q25/
Q75:7824.0/14246.3)] (Fig. 2A).
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At twelve days, CFUs demonstrated a reversed pattern, with 
a negative effect induced by A.actinomycetemcomitans-
bacterial-fragments on G-MSCs’ numbers. CFUs were 
highest in the negative-control group, and with increas-
ing A.actinomycetemcomitans-bacterial fragments’ 
concentration, a steady reduction in CFUs was noted. 
On average 45.5 CFUs were observed in the negative-
control group, 25 CFUs in the 15 µg/ml group, 19 CFUs 
in the 60 µg/ml group, 15.5 CFUs in the 120 µg/ml 
group and 6 CFUs in the 240 µg/ml group (Fig. 2B).
-Inflammatory and regenerative transcription factors’ 
expression 
Challenging G-MSCs with total sonicated 
A.actinomycetemcomitans-bacterial fragments re-
sulted in a significantly increased NFKB1 expression, 
with increasing A.actinomycetemcomitans-bacterial-
fragments’ concentrations (p=0.017; Friedman-test). 
A significant increase was observed between the neg-
ative-control group and the 120 µg/ml (p=0.037) as 
well as the 240 µg/ml A.actinomycetemcomitans-bac-
terial-fragments groups (p=0.003; Wilcoxon-signed-
rank-test). ALPL expression was significantly altered 
by the different A.actinomycetemcomitans-bacterial-
fragments’ concentrations (p=0.017; Friedman test), 
with a significant reduction in expression reached be-
tween the negative-control group on one hand and 15 
µg/ml (p=0.005), 60 µg/ml (p=0.041) and 120 µg/ml 
A.actinomycetemcomitans-bacterial-fragments groups 
(p=0.019; Wilcoxon-signed-rank-test) on the other. 
ALPL expression however demonstrated a significant 
increase over-time (p=0.035; Friedman-test), which was 
mostly attributable to the increased expression observed 
in the control group. COL1A1 expression showed a sig-
nificant rise with increasing A.actinomycetemcomitans-
bacterial-fragments’ challenge (p=0.025; Friedman-test), 
with a significance level reached between 15 µg/ml and 
60 µg/ml (p=0.012) as well as between 15 µg/ml and 240 
µg/ml A.actinomycetemcomitans-bacterial-fragments 
groups (p=0.003; Wilcoxon-signed-rank-test). COL3A1 
expression showed no significant difference with increas-
ing total A.actinomycetemcomitans-bacterial-fragments’ 
concentration (p=0.078; Friedman-test). A significantly 
increased SPARC expression was further observed with 
increasing A.actinomycetemcomitans-bacterial-frag-
ments’ concentration (p=0.025; Friedman-test) and a sig-
nificance level was reached between the negative-control 
group and 240 µg/ml (p=0.023) as well as between 15 
µg/ml and 240 µg/ml A.actinomycetemcomitans-bac-
terial-fragments (p=0.002; Wilcoxon-signed-rank-test). 
SPP1 expression showed no significant differences with 
increasing A.actinomycetemcomitans-bacterial-frag-
ments’ concentration (p=0.377; Friedman-test). Apart 
from elevated ALPL expression, no significant differenc-
es were notable over time (between 24, 28 and 72 hours) 
for the investigated markers (Fig. 3). 
Discussion
The rapidly-progressing LAgP, is predominantly asso-
ciated with the presence of a highly virulent Gram-neg-
ative microflora, primarily A.actinomycetemcomitans, 
and an accompanying aggressive inflammatory re-
sponse, culminating in excessive destruction of peri-
odontal/tooth-supporting tissues (5). Bacterial patho-
gens and their associated molecules/virulence factors, 
detected through receptors of tissue-resident cells of the 
innate immune system play hereby a pivotal role, induc-
ing the production, activation and secretion of inflam-
matory mediators (27), with resultant vasodilation and 
plasma leakage into the infected tissues, inflammatory 
cells’ recruitment and an imbalance in the host’s inflam-
matory response (28). If the A.actinomycetemcomitans 
challenge, especially A.actinomycetemcomitans of se-
rovar-b, is not eliminated, through this tissue specific 
acute inflammatory response or/and the professional 
periodontal treatment, persisting in the periodontal 
crevice, severe tissue damage with a high rate of attach-
ment loss and disease progression may occur (9), with 
a subsequent tooth loss at an early age and profound 
cosmetic, functional, and psychological effects (29). 
Multiple investigations demonstrated the effectiveness 
of sonic/ultrasonic devices in root surface debridement 
(30,31), with easier and faster root detoxification (17), 
disruption of the biofilm and reduction in the microbial 
load (16), producing a biologically compatible environ-
ment for reattachment/new attachment of adjacent peri-
odontal tissues and their cells (15).
Tissue resident G-MSCs in the gingival lamina pro-
pria niche (20), show noteworthy periodontal tissue 
reparative/regenerative potential (32,33), remarkable 
immunomodulatory properties (21,34,35) and are more 
resistant to inflammatory stimuli than other oral mes-
enchymal stem/progenitor cells (36). During periodon-
tal treatment of LAgP, G-MSCs may come in contact 
with A.actinomycetemcomitans and its sonicated bacte-
rial fragments. The current study investigated the im-
pact of different concentrations and exposure times of 
sonicated serovar-b A.actinomycetemcomitans-bacteri-
al-fragments on G-MSCs’ proliferation and regenera-
tive transcription factors’ expression. Sonication was 
standardized to exclude any human variables. Simi-
lar to previous investigations on this line of G-MSCs 
(21,32,33,37,38), the isolated cells showed all predefined 
mesenchymal stem/progenitor cells characteristics, 
confirming their multipotent identity, with plastic-ad-
herence, CFUs formation and a multilineage differen-
tiation potential into osteogenic, adipogenic and chon-
drogenic directions. 
Earlier studies investigating single 
A.actinomycetemcomitans-associated virulence factors 
in isolation on human cells, including different adhes-
ins and fimbriae (39), Cdt, LtxA and LPS (12), demon-
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strated their capacity to cause imbalance in the host’s 
inflammatory response, primarily through their ability 
to activate and kill inflammatory cells. Cdt inhibited 
the proliferation of human oral epithelial cells, but not 
periodontal ligament fibroblasts or cementoblasts (40). 
It further upregulated the expression of the Receptor 
activator of nuclear factor kappa-B ligand (RANKL), 
a crucial factor in osteoclastogenesis, in gingival fibro-
blasts and periodontal ligament cells (41). LtxA selec-
tively distressed human cells of haematopoietic origin, 
by binding to the lymphocyte function-associated-
receptor-1 (LFA-1), causing a disruption in their mem-
brane integrity (42). Apart from triggering death of de-
fense cells, LtxA together with LPS induced a massive 
pro-inflammatory response in human monocytes/mac-
rophages with a resultant IL-1β-induced exaggerated 
bone loss (43,44). On immunological level, sonicated 
A.actinomycetemcomitans-bacterial-fragments were 
shown to induce IL-8 expression in gingival epithelial 
cells (45) and to exert a dose-dependent immunosup-
pressive effect via CD8 activation (46) and CD4/CD8 
ratio disruption (47). 
In contrast, the current study investigated the inflam-
matory-induced regenerative effect of total sonicated 
A.actinomycetemcomitans-bacterial-fragments on G-
MSCs. During their tissue regenerative approaches, 
G-MSCs, similar to other stem/progenitor cells, pass 
through a primary cellular proliferative phase, followed 
by a consequent differentiation one, to finally repair/
regenerate the injured tissues. Both cell numbers and 
differentiation capacity of the stem/progenitor cells are 
hereby pivotal to the final regenerative outcome in clini-
cal application (48). 
A sonicated A.actinomycetemcomitans-bacterial-frag-
ments’ challenge resulted in an inflammatory response, 
branded by a significantly upregulated NF-κβ m-RNA 
expression in G-MSCs. The earlier reported resistance of 
G-MSCs to inflammatory challenges (36) was evident by 
the initial non-significant NF-κβ increase observed with 
15 and 60 µg/ml A.actinomycetemcomitans-bacterial 
fragments’ concentrations. At higher concentrations, a 
substantial inflammatory response, branded by a signif-
icant upregulation in NF-κβ, was observed. Thus, it can 
be assumed that sonicated A.actinomycetemcomitans-
bacterial-fragments successfully stimulated G-MSCs, 
inducing a predictable dose dependent inflammatory 
response. 
In contrast to earlier studies on keratinocytes (49) and 
fibroblasts (50), an A.actinomycetemcomitans-bacterial-
fragments’ challenge for up to 72 hours, further stimu-
lated a remarkable G-MSCs’ proliferative activity, with 
a marked time-dependent surge in cell number, reach-
ing up to two-fold increase compared to the negative-
controls. Differences in cellular sources and their spe-
cific responses, A.actinomycetemcomitans-fragments’ 
serovars, preparation protocols, concentrations and 
stimulation durations could account for the observed 
differences. This short-term stimulation appeared ben-
eficial in increasing G-MSCs’ quantities, to participate 
in the subsequent differentiation and tissue reparative/
regenerative phases. In contrast, a longer-term total 
sonicated A.actinomycetemcomitans-bacterial frag-
ments’ challenge for twelve days, exerted a detrimental 
effect on the G-MSCs’ cellular quantities. These results 
clearly highlight the specific nature of G-MSCs, their 
resistance to short-termed inflammatory stimuli and 
their positive attributes in field of regeneration under 
inflammatory challenge.
The respective expression of regenerative transcription 
factors, following the inflammatory challenge, on the 
other hand, showed a special pattern and points at an 
inflammatory-induced reparative/regenerative reac-
tion (51). While ALPL expression showed a reduction 
with increasing A.actinomycetemcomitans-bacterial 
fragments’ concentration, its overall expression in-
creased over 72 hours. Interestingly COL1A1 and 
SPARC expressions demonstrated the opposite trend, 
with a marked inflammatory-induced increase in their 
m-RNA expression. The observed downregulation of 
ALPL and the upregulation in COL1A1 with inflam-
mation is hereby comparable to recent results observed 
in periodontal ligament stem cells isolated from in-
flamed human periodontal tissues (i-PDLSCs) (52), 
where inflammatory challenge similarly favored ma-
ture matrix forming genes’ expression and hindered 
matrix mineralization. It appears that with increasing 
sonicated A.actinomycetemcomitans-bacterial frag-
ments’ challenge, G-MSCs enter their maturation 
phase into committed gingival connective tissue cells, 
with reduced ALPL expression, whose upregulation 
is characteristic for uncommitted mesenchymal stem/
progenitor cells as well as differentiated osteoblasts 
(53). Concomitantly, an accompanying upregulation 
in extracellular matrix proteins’ expression of differ-
entiating gingival connective tissue cells, including 
COL1A1 and SPARC (54), occurs. However due to the 
sonicated A.actinomycetemcomitans-bacterial frag-
ments’ short stimulation time, of maximum 72 hours in 
the present study, it is difficult to conclude whether the 
downregulated ALPL expression observed should be 
attributed to an inflammation-induced differentiation 
process of G-MSCs to committed gingival extracellular 
matrix producing cells or to the reported effect of the 
A.actinomycetemcomitans-induced interference with 
cellular osteogenic mineralization phases (52,55,56). 
A.actinomycetemcomitans-bacterial fragments’ pro-
duced via sonic/ultrasonication exert positive short-
term effects on G-MSCs, primarily through stimulating 
their proliferative and non-mineralized tissue differen-
tiating aptitude. Taking into consideration the physical 
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effect of the sonic/ultrasonic oscillating tips, increas-
ing the convection in the subgingival fluid via acous-
tic micro-streaming, in addition to its gingival crev-
ice washing effect, it is reasonable to assume that the 
A.actinomycetemcomitans-bacterial fragments would 
remain in contact with the gingival soft tissue cells for 
a short time and at low concentrations following instru-
mentation. Thus, the outlined longer-term unfavorable 
effects are more remote to happen in clinical settings. 
Current results shed a new light on the importance of 
regular periodontal treatment for LAgP patients, using 
power driven sonic/ultrasonic devices, which, in addition 
to reducing the general subgingival microbial load, and 
in contrast to hand instruments, produce cell stimulatory 
A.actinomycetemcomitans-bacterial fragments with 
positive attributes on reparative/regenerative responses 
of tissue resident gingival stem/progenitor cells.
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